This report aims to provide a comprehensive presentation of the global market for Pulmonary & Respiratory Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary & Respiratory Drug Delivery. This report contains market size and forecasts of Pulmonary & Respiratory Drug Delivery in global, including the following market information:
Global Pulmonary & Respiratory Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pulmonary & Respiratory Drug Delivery market was valued at US$ 32470 million in 2022 and is projected to reach US$ 41390 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Suspension Aerosol Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pulmonary & Respiratory Drug Delivery include Merck, Teva Pharmaceutical, 3M, Astrazeneca, Boehringer Ingelheim, Cipla, Glaxosmithkline, Novartis and Omron Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pulmonary & Respiratory Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary & Respiratory Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pulmonary & Respiratory Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Suspension Aerosol
Solution Aerosol
Dry Powder Formulation
Global Pulmonary & Respiratory Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pulmonary & Respiratory Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospitals
Home Care
Global Pulmonary & Respiratory Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pulmonary & Respiratory Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary & Respiratory Drug Delivery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pulmonary & Respiratory Drug Delivery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva Pharmaceutical
3M
Astrazeneca
Boehringer Ingelheim
Cipla
Glaxosmithkline
Novartis
Omron Corporation
Sunovion Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pulmonary & Respiratory Drug Delivery, market overview.
Chapter 2: Global Pulmonary & Respiratory Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Pulmonary & Respiratory Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pulmonary & Respiratory Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pulmonary & Respiratory Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary & Respiratory Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary & Respiratory Drug Delivery Overall Market Size
2.1 Global Pulmonary & Respiratory Drug Delivery Market Size: 2022 VS 2029
2.2 Global Pulmonary & Respiratory Drug Delivery Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pulmonary & Respiratory Drug Delivery Players in Global Market
3.2 Top Global Pulmonary & Respiratory Drug Delivery Companies Ranked by Revenue
3.3 Global Pulmonary & Respiratory Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Pulmonary & Respiratory Drug Delivery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pulmonary & Respiratory Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pulmonary & Respiratory Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Pulmonary & Respiratory Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Pulmonary & Respiratory Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary & Respiratory Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Suspension Aerosol
4.1.3 Solution Aerosol
4.1.4 Dry Powder Formulation
4.2 By Type - Global Pulmonary & Respiratory Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Pulmonary & Respiratory Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Pulmonary & Respiratory Drug Delivery Revenue, 2024-2029
4.2.3 By Type - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary & Respiratory Drug Delivery Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Home Care
5.2 By Application - Global Pulmonary & Respiratory Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Pulmonary & Respiratory Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Pulmonary & Respiratory Drug Delivery Revenue, 2024-2029
5.2.3 By Application - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pulmonary & Respiratory Drug Delivery Market Size, 2022 & 2029
6.2 By Region - Global Pulmonary & Respiratory Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Pulmonary & Respiratory Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Pulmonary & Respiratory Drug Delivery Revenue, 2024-2029
6.2.3 By Region - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pulmonary & Respiratory Drug Delivery Revenue, 2018-2029
6.3.2 US Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.3.3 Canada Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.3.4 Mexico Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pulmonary & Respiratory Drug Delivery Revenue, 2018-2029
6.4.2 Germany Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.4.3 France Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.4.4 U.K. Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.4.5 Italy Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.4.6 Russia Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.4.7 Nordic Countries Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.4.8 Benelux Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pulmonary & Respiratory Drug Delivery Revenue, 2018-2029
6.5.2 China Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.5.3 Japan Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.5.4 South Korea Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.5.5 Southeast Asia Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.5.6 India Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pulmonary & Respiratory Drug Delivery Revenue, 2018-2029
6.6.2 Brazil Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.6.3 Argentina Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pulmonary & Respiratory Drug Delivery Revenue, 2018-2029
6.7.2 Turkey Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.7.3 Israel Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.7.4 Saudi Arabia Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
6.7.5 UAE Pulmonary & Respiratory Drug Delivery Market Size, 2018-2029
7 Pulmonary & Respiratory Drug Delivery Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.1.4 Merck Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Teva Pharmaceutical
7.2.1 Teva Pharmaceutical Company Summary
7.2.2 Teva Pharmaceutical Business Overview
7.2.3 Teva Pharmaceutical Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.2.4 Teva Pharmaceutical Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Key News & Latest Developments
7.3 3M
7.3.1 3M Company Summary
7.3.2 3M Business Overview
7.3.3 3M Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.3.4 3M Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.3.5 3M Key News & Latest Developments
7.4 Astrazeneca
7.4.1 Astrazeneca Company Summary
7.4.2 Astrazeneca Business Overview
7.4.3 Astrazeneca Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.4.4 Astrazeneca Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.4.5 Astrazeneca Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.5.4 Boehringer Ingelheim Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Cipla
7.6.1 Cipla Company Summary
7.6.2 Cipla Business Overview
7.6.3 Cipla Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.6.4 Cipla Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.6.5 Cipla Key News & Latest Developments
7.7 Glaxosmithkline
7.7.1 Glaxosmithkline Company Summary
7.7.2 Glaxosmithkline Business Overview
7.7.3 Glaxosmithkline Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.7.4 Glaxosmithkline Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.7.5 Glaxosmithkline Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.8.4 Novartis Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Omron Corporation
7.9.1 Omron Corporation Company Summary
7.9.2 Omron Corporation Business Overview
7.9.3 Omron Corporation Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.9.4 Omron Corporation Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.9.5 Omron Corporation Key News & Latest Developments
7.10 Sunovion Pharmaceuticals
7.10.1 Sunovion Pharmaceuticals Company Summary
7.10.2 Sunovion Pharmaceuticals Business Overview
7.10.3 Sunovion Pharmaceuticals Pulmonary & Respiratory Drug Delivery Major Product Offerings
7.10.4 Sunovion Pharmaceuticals Pulmonary & Respiratory Drug Delivery Revenue in Global Market (2018-2023)
7.10.5 Sunovion Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pulmonary & Respiratory Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Pulmonary & Respiratory Drug Delivery Market Drivers in Global Market
Table 3. Pulmonary & Respiratory Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Pulmonary & Respiratory Drug Delivery in Global Market
Table 5. Top Pulmonary & Respiratory Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pulmonary & Respiratory Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pulmonary & Respiratory Drug Delivery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pulmonary & Respiratory Drug Delivery Product Type
Table 9. List of Global Tier 1 Pulmonary & Respiratory Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary & Respiratory Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pulmonary & Respiratory Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pulmonary & Respiratory Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pulmonary & Respiratory Drug Delivery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pulmonary & Respiratory Drug Delivery Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Pulmonary & Respiratory Drug Delivery Product Offerings
Table 32. Merck Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Teva Pharmaceutical Company Summary
Table 35. Teva Pharmaceutical Pulmonary & Respiratory Drug Delivery Product Offerings
Table 36. Teva Pharmaceutical Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceutical Key News & Latest Developments
Table 38. 3M Company Summary
Table 39. 3M Pulmonary & Respiratory Drug Delivery Product Offerings
Table 40. 3M Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 41. 3M Key News & Latest Developments
Table 42. Astrazeneca Company Summary
Table 43. Astrazeneca Pulmonary & Respiratory Drug Delivery Product Offerings
Table 44. Astrazeneca Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 45. Astrazeneca Key News & Latest Developments
Table 46. Boehringer Ingelheim Company Summary
Table 47. Boehringer Ingelheim Pulmonary & Respiratory Drug Delivery Product Offerings
Table 48. Boehringer Ingelheim Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 49. Boehringer Ingelheim Key News & Latest Developments
Table 50. Cipla Company Summary
Table 51. Cipla Pulmonary & Respiratory Drug Delivery Product Offerings
Table 52. Cipla Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 53. Cipla Key News & Latest Developments
Table 54. Glaxosmithkline Company Summary
Table 55. Glaxosmithkline Pulmonary & Respiratory Drug Delivery Product Offerings
Table 56. Glaxosmithkline Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 57. Glaxosmithkline Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Pulmonary & Respiratory Drug Delivery Product Offerings
Table 60. Novartis Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Omron Corporation Company Summary
Table 63. Omron Corporation Pulmonary & Respiratory Drug Delivery Product Offerings
Table 64. Omron Corporation Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 65. Omron Corporation Key News & Latest Developments
Table 66. Sunovion Pharmaceuticals Company Summary
Table 67. Sunovion Pharmaceuticals Pulmonary & Respiratory Drug Delivery Product Offerings
Table 68. Sunovion Pharmaceuticals Pulmonary & Respiratory Drug Delivery Revenue (US$, Mn) & (2018-2023)
Table 69. Sunovion Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Pulmonary & Respiratory Drug Delivery Segment by Type in 2022
Figure 2. Pulmonary & Respiratory Drug Delivery Segment by Application in 2022
Figure 3. Global Pulmonary & Respiratory Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pulmonary & Respiratory Drug Delivery Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pulmonary & Respiratory Drug Delivery Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pulmonary & Respiratory Drug Delivery Revenue in 2022
Figure 8. By Type - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 16. US Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 20. Germany Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 21. France Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 28. China Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 32. India Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 34. Brazil Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pulmonary & Respiratory Drug Delivery Revenue Market Share, 2018-2029
Figure 37. Turkey Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pulmonary & Respiratory Drug Delivery Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceutical Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. 3M Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astrazeneca Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Boehringer Ingelheim Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cipla Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Glaxosmithkline Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Omron Corporation Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sunovion Pharmaceuticals Pulmonary & Respiratory Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
